Hua Zhang, Yuanchun Zhao, Jiao Zhao, Xinhang Wang, Hong Fang, Min Chen et al. Combined baicalein and the neocryptolepine derivative Z2 enhance anti-ovarian cancer efficacy by inhibiting the CDK4/6-Rb signaling pathway. // Toxicology and Applied Pharmacology. – 2027. – DOI: 10.1016/j.taap.2026.118099. – URL: https://doi.org/10.1016/j.taap.2026.118099
Hua Zhang, Yuanchun Zhao, Jiao Zhao, Xinhang Wang, Hong Fang, Min Chen, Yuqi Yue, Rui Yang, Xin Ma, Liqian Du, Yingqian Liu, & Peng Chen (2027). Combined baicalein and the neocryptolepine derivative Z2 enhance anti-ovarian cancer efficacy by inhibiting the CDK4/6-Rb signaling pathway. Toxicology and Applied Pharmacology. https://doi.org/10.1016/j.taap.2026.118099
Hua Zhang, et al. “Combined baicalein and the neocryptolepine derivative Z2 enhance anti-ovarian cancer efficacy by inhibiting the CDK4/6-Rb signaling pathway.” Toxicology and Applied Pharmacology, 2027. doi:10.1016/j.taap.2026.118099.
@article{Zhang2027,
title = {Combined baicalein and the neocryptolepine derivative Z2 enhance anti-ovarian cancer efficacy by inhibiting the CDK4/6-Rb signaling pathway},
author = {Zhang, Hua and Zhao, Yuanchun and Zhao, Jiao and Wang, Xinhang and Fang, Hong and Chen, Min and Yue, Yuqi and Yang, Rui and Ma, Xin and Du, Liqian and Liu, Yingqian and Chen, Peng},
journal = {Toxicology and Applied Pharmacology},
year = {2027},
doi = {10.1016/j.taap.2026.118099},
url = {https://doi.org/10.1016/j.taap.2026.118099}
}